Recalls / Firms / Upsher Smith Laboratories, Inc.
Upsher Smith Laboratories, Inc.
6 FDA drug recalls on record.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2019-07-29 | Class II | Bexarotene | Terminated |
| 2018-09-19 | Class II | Bumetanide | Terminated |
| 2018-09-19 | Class II | Bumetanide | Terminated |
| 2014-04-14 | Class III | Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher | Terminated |
| 2012-12-10 | Class III | Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count t | Terminated |
| 2012-11-20 | Class II | Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Ma | Terminated |